News & Updates

Maintenance niraparib a boon in advanced ovarian cancer
Maintenance niraparib a boon in advanced ovarian cancer
24 Jun 2022 byJairia Dela Cruz

Use of niraparib in the maintenance setting appears to minimize the risk of progression in advanced ovarian cancer patients, with surgical timing having little to no effect on the drug’s efficacy, as shown in a post hoc analysis of the phase III PRIMA/ENGOT-OV26/GOG-3012 study.

Maintenance niraparib a boon in advanced ovarian cancer
24 Jun 2022